Back to Search Start Over

Family communication about genomic sequencing: A qualitative study with cancer patients and relatives.

Authors :
Smit AK
Bartley N
Best MC
Napier CE
Butow P
Newson AJ
Tucker K
Ballinger ML
Thomas DM
Jacobs C
Meiser B
Goldstein D
Savard J
Juraskova I
Source :
Patient education and counseling [Patient Educ Couns] 2021 May; Vol. 104 (5), pp. 944-952. Date of Electronic Publication: 2020 Oct 20.
Publication Year :
2021

Abstract

Objective: This study explored family communication about undertaking genomic sequencing, and intentions to communicate pertinent heritable results to family members.<br />Methods: Semi-structured interviews were conducted with cancer patients (n = 53) and their relatives (n = 20) who underwent germline genome sequencing or molecular tumor testing. Interviews were audio-recorded, transcribed and analyzed using thematic analysis.<br />Results: Key themes relevant to family communication about undertaking sequencing included: perceiving family member interest, delaying discussion until results were received, having shared capacity to understand and cope, and having open communication in the family. Intended communication subsequent to receiving results was affected by: disease severity, risk management options, degree of closeness in the family, sense of responsibility, and potential adverse impacts on family. Resource and support needs varied based on the complexity of test results, health professionals' availability, and disease severity. Unique subthemes were identified for specific subgroups.<br />Conclusion: Current findings support the need to assess the impact and resource needs specific to each clinical application of genomic sequencing.<br />Practice Implications: Increasingly sophisticated and complex clinical genomic sequencing warrants development of family-centered interventions and resources to facilitate preference-sensitive communication about genomic sequencing, including disseminating relevant information to family members.<br />Competing Interests: Declaration of Competing Interest BM has a remunerated consultant role with the company AstraZeneca with respect to an unrelated project. The other authors declare no conflicts of interest.<br /> (Copyright © 2020 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-5134
Volume :
104
Issue :
5
Database :
MEDLINE
Journal :
Patient education and counseling
Publication Type :
Academic Journal
Accession number :
33129629
Full Text :
https://doi.org/10.1016/j.pec.2020.10.022